Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial (Q28236008)
Jump to navigation
Jump to search
scientific article (publication date: 15 April 2006)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial |
scientific article (publication date: 15 April 2006) |
Statements
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial (English)
0 references
15 April 2006
0 references
367
0 references
1247-55
0 references
9518
0 references